XML 37 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows
$ in Thousands
12 Months Ended
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Operating activities    
Net income (loss) $ 19,660 $ (39,421)
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:    
Non-cash interest expense 7,141 6,379
Share-based compensation expense 4,477 6,207
Amortization of intangible assets 1,552 647
Amortization of right-of-use lease assets 218 1,249
Depreciation expense 111 2,188
Inventory fair value step-up adjustment included in cost of product sales 850 2,458
Gain on change in fair value of contingent value rights (734) (800)
Loss on short-term investments   502
Loss on disposal of property and equipment, net of gain on lease termination   10
Changes in operating assets and liabilities:    
Accounts receivable, net (2,776) (1,687)
Inventory, net (1,118) (1,493)
Prepaid expenses and other current assets (2,368) 2,297
Accounts payable (484) (2,815)
Accrued expenses (728) (11,423)
Deferred revenue 2,661 188
Lease liabilities (218) (2,126)
Net cash provided by (used for) operating activities 28,244 (37,640)
Investing activities    
Acquisition of Tetraphase, net of cash, cash equivalents and restricted cash acquired   (33,513)
Proceeds from the sale of property and equipment   3,070
Purchases of property and equipment (9)  
Proceeds from the sale of short-term investments   2,497
Purchases of short-term investments   (2,999)
Net cash used for investing activities (9) (30,945)
Financing activities    
Purchases of common stock under Stock Repurchase Plan (3,380)  
Net proceeds from issuance of common stock under ESPP 436 512
Net proceeds from issuance of common stock under 2013 Equity Plan 156 605
Net cash (used for) provided by financing activities (2,788) 1,117
Net increase (decrease) in cash, cash equivalents and restricted cash 25,447 (67,468)
Cash, cash equivalents and restricted cash, beginning of period 21,261 88,729
Cash, cash equivalents and restricted cash, end of period 46,708 21,261
Supplemental disclosure of non-cash investing and financing activities    
Initial recognition of right-of-use lease asset   536
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets    
Cash and cash equivalents 46,668 21,221
Restricted cash 40 40
Cash, cash equivalents and restricted cash, end of period $ 46,708 $ 21,261